FDA Inspection 1137344 — Ionetix Corporation
The FDA completed an inspection of Ionetix Corporation on February 25, 2021 in Kansas City, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 25, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kansas City, KS (United States)